Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 6/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29300517 | 0.87 | FOLH1 (0.65) | FOLH1HDAC3HDAC1HDAC6 | |
| SCHEMBL22106236 | 0.85 | HDAC1 (0.56) | TSHRSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL18811751 | 0.85 | HDAC1 (0.56) | TSHRSMN1; SMN2KMT2AMEN1ALDH1A1 | |
| SCHEMBL16297725 | 0.85 | HTT (0.57) | HTTUSP2LMNAKMT2AGAA | |
| SCHEMBL18659987 | 0.84 | CA1 (0.60) | HTTUSP2LMNAKMT2AGAA | |
| SCHEMBL10284232 | 0.83 | GAA (0.55) | FOLH1HTTUSP2LMNATSHR | |
| SCHEMBL29299810 | 0.82 | FOLH1 (0.70) | FOLH1HTTLMNATSHRKMT2A | |
| SCHEMBL23504877 | 0.80 | FOLH1 (0.68) | FOLH1TSHRKMT2AMEN1HDAC3 | |
| SCHEMBL24115204 | 0.80 | FOLH1 (0.62) | FOLH1TSHRKMT2AMEN1HDAC3 | |
| SCHEMBL23504874 | 0.77 | FOLH1 (0.67) | FOLH1HDAC3HDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919938-B2 | Modified cyclopentapeptides and uses thereof | Technische Universität München (DE) | 2021-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919938-B2 | Modified cyclopentapeptides and uses thereof | ANXA4, CPA4, PTMS | FOLH1 259/4885HTT 945/4885USP2 2897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.